The tweet was deleted by the author.
But we saved everything 🙂.
NeuroPace Inc reported revenue of 22.1 million for the first quarter of 2026, driven by approximately 20 percent year over year growth in its RNS System segment.
The company also raised its full year guidance, citing strong operating leverage and continued momentum across market, clinical, and product development. NeuroPace Inc indicated a clear roadmap ahead, along with plans for a webcast to discuss full results.
NeuroPace has recently highlighted life changing outcomes from a three-year post approval study of its RNS System. The company has also hosted a free webinar for epilepsy patients offering a live Q&A on the RNS System treatment. Both initiatives follow ongoing product and clinical development efforts.